Biotinyl-GHK: A Miracle Ingredient Against Hair Loss?

The search for effective solutions to combat hair loss has led to the research of various bioactive compounds. Among them, biotinyl-GHK has emerged as a promising ingredient in hair treatments. This article explores in depth what biotinyl-GHK is, its mechanism of action, and the scientific evidence supporting its use in the prevention and treatment of alopecia.

What is Biotinyl-GHK?

Biotinyl-GHK is a bioactive peptide composed of three essential amino acids—glycine, histidine, and lysine—to which a biotin molecule has been attached. This combination makes it an innovative ingredient in hair care, as it takes advantage of the regenerative properties of the tripeptide GHK and the strengthening capabilities of biotin.

To better understand its importance, we will break down each of its components:

Tripeptide GHK (Glycine-Histidine-Lysine)

is a peptide that is found naturally in the human body and plays a key role in tissue repair, healing, and cell regeneration.

In the context of hair growth, GHK-Cu has been observed to help cells within hair follicles multiply more quickly, which promotes hair regeneration. In addition, it reduces programmed cell death (apoptosis) in the follicles, preventing them from weakening and losing their ability to produce hair. At the same time, it improves the scalp environment by reducing inflammation and oxidative damage, factors that often contribute to hair loss. All of this creates more favorable conditions for hair to grow stronger and healthier.

Scientific research has backed up these benefits of GHK-Cu, but we need to take it with a grain of salt. For example, studies have shown that this peptide promotes skin remodeling, wound healing, and regeneration, as well as exhibiting notable antioxidant and anti-inflammatory effects in in vitro and in vivo studies. These findings suggest that GHK-Cu may be a promising therapeutic agent in the treatment of conditions related to aging and hair loss.

First, most research has been conducted in vitro or in animal models, which does not always guarantee the same results in humans. In addition, large-scale, long-term clinical trials confirming its effectiveness and safety in different types of patients are lacking. Another challenge is the lack of consensus on the ideal dosage and best route of administration, as it has been studied primarily in topical applications. There is also the risk of interactions with copper, since although GHK-Cu safely transports copper, an excess of this metal in the body can induce oxidative stress.

Another point to consider is the lack of regulation and standardization in the production of GHK-Cu, which generates variability in the quality of the products available on the market. In addition, some studies have been funded by companies interested in marketing peptides, which could influence their conclusions. Finally, although studies suggest that GHK-Cu can promote hair growth, there is not enough evidence to claim that it is more effective than standard treatments such as minoxidil or finasteride, since direct comparisons have not been made in clinical trials.

Biotin

As we already said in our article Biotin: The star ingredient in hair products. Biotin, also known as vitamin B7 or vitamin H, is an essential nutrient that is involved in the metabolism of carbohydrates, fats and proteins. It is found naturally in foods such as eggs, nuts and legumes. Its link to hair health comes from its role in the production of keratin, a key protein in the structure of hair, skin and nails. However, although biotin deficiency can lead to hair weakening and nail brittleness, it is rare in people with a balanced diet.

The marketing of many biotin products can be misleading and it is also important to mention this. As it suggests that any hair problem can be solved by simply taking supplements of this vitamin, when in reality hair loss is a multifactorial phenomenon. There are many causes of alopecia, from genetic factors (such as androgenic alopecia) to hormonal problems, stress, autoimmune diseases or side effects of medications. In addition, hair can be weakened by deficiencies of other vitamins and minerals such as iron, zinc, vitamin D or proteins.

Interest in peptides

Companies are interested in commercializing peptides due to their increasing demand in the cosmetic and dermatological industry. According to a report by Mordor Intelligence, the cosmetic peptide synthesis market is expected to register a compound annual growth rate (CAGR) of 5.5% during the forecast period up to 2028. This interest is due to the beneficial properties of peptides in skin and hair care. Peptides are known for their ability to stimulate collagen production, improve skin barrier function, reduce inflammation, and correct pigmentation issues, making them highly sought after in the skin care industry.

Furthermore, unlike drugs such as finasteride or minoxidil, which require strict regulatory approval for use in hair treatments, many peptides can be marketed as cosmetic ingredients or supplements with less stringent regulations. This allows companies to introduce products to the market more quickly and with lower costs associated with regulatory compliance.

Collagen: the common point of biotin and GHK Tripeptide

Collagen is one of the most abundant proteins in the human body and plays a fundamental role in the health of the skin, connective tissues and, of course, hair. Both biotin and GHK tripeptide are related to the production and maintenance of collagen, which explains their synergy in hair products.

On the one hand, biotin (vitamin B7) contributes to the synthesis of keratin, a key structural protein of hair, skin and nails. Its deficiency can cause hair fragility, hair loss and weakening of hair fibers. Although it does not act directly on collagen production, it does play a role in the health of tissues that depend on this protein, as it participates in the metabolism of fatty acids and amino acids essential for its formation. On the other hand, the tripeptide GHK (glycine-histidine-lysine) is known for its ability to stimulate collagen production in the skin and connective tissues. This peptide has been shown to have regenerative properties, promoting wound healing and cell repair. Its union with biotin in Biotinil-GHK enhances its effect on the hair follicle, as it improves hair regeneration and reinforces the extracellular matrix of the scalp.

Together, these two compounds help strengthen hair follicles from the root, promoting healthier and more resistant hair growth. Collagen acts as a structural support for the hair, while biotin and GHK stimulate its production and regeneration. This relationship explains why many hair loss products combine these ingredients, seeking to maximize their benefits at the cellular and structural level.

Biotinil-GHK and studies

The effectiveness of Biotinil-GHK in the treatment of hair loss has been the subject of various scientific studies. This compound, which combines biotin and the tripeptide GHK, has shown promising results in stimulating hair growth.

An in vitro study evaluated the efficacy of Biotinyl-GHK compared to minoxidil, a widely recognized treatment for alopecia. The results indicated that Biotinyl-GHK increased hair growth by 121%, while minoxidil did so by 58% BIOLIFE.CL . These findings suggest that Biotinyl-GHK could be more effective than minoxidil in promoting hair growth.

In addition, Biotinyl-GHK has been observed to stimulate the production of collagen type IV and laminin 5 in dermal and epidermal cells, which strengthens the structure of the hair follicle and improves its anchorage. This action contributes to the reduction of hair loss and the strengthening of the follicles.

However, it is important to note that while these preliminary studies are encouraging, research on Biotinyl-GHK is still limited. Further large-scale clinical studies are required to confirm its efficacy and safety in different populations. As always, it is advisable to consult with a healthcare professional before starting any hair loss treatment. Regarding the community, Users have noted improvements in hair density and a reduction in hair loss after consistent use of products containing Biotinyl-GHK. However, the effectiveness of such treatments can be influenced by individual responses and the specific combination of ingredients used in the formulations.

sources

Pickart, L., & Margolina, A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 19(7), 1987. https://doi.org/10.3390/ijms19071987

Pavithra, T. R., Rajashekar, T. S., Suresh Kumar, K., & Harish Prasanna. (2023). A Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia. Cureus, 15(5), e38696. https://doi.org/10.7759/cureus.38696

Samadi, A., & Rokhsat, E. (2022). Assessment of the efficacy and tolerability of a topical formulation containing caffeine and Procapil 3% for improvement of male pattern hair loss. Journal of Cosmetic Dermatology, 21(11), 5602-5604. https://doi.org/10.1111/jocd.16102

Koch, E., & Esdaile, D. J. (2007). Reduction of Hair-loss: Matrikines and plant molecules to the rescue. Journal of Cosmetic Dermatology, 6(1), 37-40. https://doi.org/10.1111/j.1473-2165.2007.00300.x

Trüeb, R. M. (2016). A Comparative Study Between Topical 5% Minoxidil and Topical Redensyl, Capixyl, and Procapil Combination in Men With Androgenetic Alopecia. Journal of Clinical and Aesthetic Dermatology, 9(9), 27-34. https://www.hilarispublisher.com/open-access/a-comparative-study-between-topical-5-minoxidil-and-topical-redensyl-capixyl-and-procapil-combination-in-men-with-androg.pdf

Siah, T. W., & Muir, J. (2023). Combining topical minoxidil with Procapil; an assessment of their efficacy in the treatment of androgenetic alopecia. Journal of Pakistan Association of Dermatologists, 33(4), 654-659. https://www.jpad.com.pk/index.php/jpad/article/view/2541

Hafeez, F., & Ahmed, I. (2017). Efficacy and Safety of a New Topical Hair Loss-Lotion Containing Oleanolic Acid, Apigenin, Biotinyl Tripeptide-1, Diaminopyrimidine Oxide, and Panthenol in Healthy Male and Female Volunteers. Journal of Clinical and Experimental Dermatology Research, 8(2), 1000132. https://www.hilarispublisher.com/open-access/efficacy-and-safety-of-a-new-topical-hair-losslotion-containing-oleanolic-acid-apigenin-biotinyl-tripeptide1-diaminopyrimidine-oxi-2471-9323-1000132.pdf

John, A. M., Schwartz, R. A., & Janniger, C. K. (2021). Biotin for Hair Loss: Teasing Out the Evidence. Journal of Clinical and Aesthetic Dermatology, 14(1), 55-59. https://jcadonline.com/biotin-for-hair-loss-evidence/

Pickart, L., & Margolina, A. (2018). Regenerative and protective actions of the GHK-Cu peptide in light of the new gene data. International Journal of Molecular Sciences, 19(7), 1987. https://doi.org/10.3390/ijms19071987

Fry, R. J., Ham, R. G., & Calabrese, E. J. (2018). GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioResearch Open Access, 7(1), 113–123. https://doi.org/10.1089/biores.2018.0019

Maquart, F. X., Bellon, G., Chaqour, B., Wegrowski, Y., Patt, L. M., Trachy, R. E., & Pickart, L. (1993). In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. Journal of Clinical Investigation, 92(5), 2368–2376. https://doi.org/10.1172/JCI116830

Canapp, S. O., Farese, J. P., Schultz, G. S., Gowda, S., Ishak, A. M., Swaim, S. F., ... & Martin, F. G. (2003). The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Veterinary Surgery, 32(6), 515–523. https://doi.org/10.1053/jvet.2003.50072

Gul, N. Y., Topal, A., Cangul, I. T., & Yanik, K. (2008). The effects of topical tripeptide copper complex and helium-neon laser on wound healing in rabbits. Veterinary Dermatology, 19(1), 8–14. https://doi.org/10.1111/j.1365-3164.2008.00650.x

Conato, C., Gavioli, R., Guerrini, R., Kozłowski, H., & Młynarz, P. (2000). Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: Chemical behaviour and biological activity. Biochimica et Biophysica Acta (BBA) - General Subjects, 1475(1), 47–53. https://doi.org/10.1016/S0304-4165(00)00098-0

Hureau, C., Eury, H., Guillot, R., Bijani, C., Sayen, S., & Faller, P. (2011). X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: Influence on their redox properties. Chemistry -A European Journal, 17(35), 10151–10160. https://doi.org/10.1002/chem.201100654

Lau, S. J., & Sarkar, B. (1971). The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochemical Journal, 124(4), 751–757. https://doi.org/10.1042/bj1240751 Gorouhi, F., & Maibach, H. I. (2009). Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science, 31(5), 327–345. https://doi.org/10.1111/j.1468-2494.2009.00523.x

Pickart, L., & Thaler, M. M. (1973). Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biology, 243(124), 85–87. https://doi.org/10.1038/newbio243085a0

Schlesinger, D. H., & Hay, D. I. (1977). Growth-modulating serum tripeptide is glycyl-histidyl-lysine. Cellular and Molecular Life Sciences, 33(3), 317–318. https://doi.org/10.1007/BF01945327

Maquart, F. X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J. C., & Borel, J. P. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters, 238(2), 343–346. https://doi.org/10.1016/0014-5793(88)80210-3

Wegrowski, Y., Maquart, F. X., & Borel, J. P. (1992). Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Life Sciences, 51(13), 1049–1056. https://doi.org/10.1016/0024-3205(92)90505-2

Siméon, A., Emonard, H., Hornebeck, W., & Maquart, F. X. (2000). The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sciences, 67(18), 2257–2265. https://doi.org/10.1016/S0024-3205(00)00820-0

Siméon, A., Wegrowski, Y., Bontemps, Y., & Maquart, F. X. (2000). Expression of glycosaminoglycans and small proteoglycans in wounds: Modulation by the tripeptide-copper complex glycyl-L